191 related articles for article (PubMed ID: 1568575)
1. Role of circulating cholecystokinin in control of fat-induced inhibition of food intake in humans.
Drewe J; Gadient A; Rovati LC; Beglinger C
Gastroenterology; 1992 May; 102(5):1654-9. PubMed ID: 1568575
[TBL] [Abstract][Full Text] [Related]
2. Effect of a low dose of intraduodenal fat on satiety in humans: studies using the type A cholecystokinin receptor antagonist loxiglumide.
Lieverse RJ; Jansen JB; Masclee AA; Rovati LC; Lamers CB
Gut; 1994 Apr; 35(4):501-5. PubMed ID: 8174988
[TBL] [Abstract][Full Text] [Related]
3. Loxiglumide, a CCK-A receptor antagonist, stimulates calorie intake and hunger feelings in humans.
Beglinger C; Degen L; Matzinger D; D'Amato M; Drewe J
Am J Physiol Regul Integr Comp Physiol; 2001 Apr; 280(4):R1149-54. PubMed ID: 11247838
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans.
Matzinger D; Gutzwiller JP; Drewe J; Orban A; Engel R; D'Amato M; Rovati L; Beglinger C
Am J Physiol; 1999 Dec; 277(6):R1718-24. PubMed ID: 10600919
[TBL] [Abstract][Full Text] [Related]
5. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
Gutzwiller JP; Drewe J; Ketterer S; Hildebrand P; Krautheim A; Beglinger C
Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R189-95. PubMed ID: 10896881
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin in the control of gastric acid and plasma gastrin and somatostatin secretion in healthy subjects and duodenal ulcer patients before and after eradication of Helicobacter pylori.
Konturek JW
J Physiol Pharmacol; 1994 Dec; 45(4 Suppl 1):3-66. PubMed ID: 7787215
[TBL] [Abstract][Full Text] [Related]
7. Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism.
Lieverse RJ; Jansen JB; van de Zwan A; Samson L; Masclee AA; Rovati LC; Lamers CB
J Clin Endocrinol Metab; 1993 Jun; 76(6):1495-8. PubMed ID: 8501156
[TBL] [Abstract][Full Text] [Related]
8. Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion.
Schmidt WE; Creutzfeldt W; Höcker M; Nustede R; Choudhury AR; Schleser A; Rovati LC; Fölsch UR
Eur J Clin Invest; 1991 Oct; 21(5):501-11. PubMed ID: 1752290
[TBL] [Abstract][Full Text] [Related]
9. Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women.
Lieverse RJ; Masclee AA; Jansen JB; Rovati LC; Lamers CB
Biol Psychiatry; 1995 Mar; 37(5):331-5. PubMed ID: 7748985
[TBL] [Abstract][Full Text] [Related]
10. The effects of loxiglumide on food intake in normal weight volunteers.
French SJ; Bergin A; Sepple CP; Read NW; Rovati L
Int J Obes Relat Metab Disord; 1994 Nov; 18(11):738-41. PubMed ID: 7866473
[TBL] [Abstract][Full Text] [Related]
11. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans.
Matzinger D; Degen L; Drewe J; Meuli J; Duebendorfer R; Ruckstuhl N; D'Amato M; Rovati L; Beglinger C
Gut; 2000 May; 46(5):688-693. PubMed ID: 10764713
[TBL] [Abstract][Full Text] [Related]
12. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
[TBL] [Abstract][Full Text] [Related]
13. Bombesin reduces food intake after a preload in man by a cholecystokinin-independent mechanism.
Lieverse RJ; Jansen JB; Masclee AA; Lamers CB
Clin Sci (Lond); 1993 Sep; 85(3):277-80. PubMed ID: 8403798
[TBL] [Abstract][Full Text] [Related]
14. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
Konturek JW; Thor P; Maczka M; Stoll R; Domschke W; Konturek SJ
Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
[TBL] [Abstract][Full Text] [Related]
15. Elevation of feed intake in parasite-infected lambs by central administration of a cholecystokinin receptor antagonist.
Dynes RA; Poppi DP; Barrell GK; Sykes AR
Br J Nutr; 1998 Jan; 79(1):47-54. PubMed ID: 9505802
[TBL] [Abstract][Full Text] [Related]
16. Cholecystokinin's role in regulation of colonic motility in health and in irritable bowel syndrome.
Niederau C; Faber S; Karaus M
Gastroenterology; 1992 Jun; 102(6):1889-98. PubMed ID: 1587408
[TBL] [Abstract][Full Text] [Related]
17. Role of cholecystokinin in the regulation of gastric emptying and pancreatic enzyme secretion in humans. Studies with the cholecystokinin-receptor antagonist loxiglumide.
Fried M; Erlacher U; Schwizer W; Löchner C; Koerfer J; Beglinger C; Jansen JB; Lamers CB; Harder F; Bischof-Delaloye A
Gastroenterology; 1991 Aug; 101(2):503-11. PubMed ID: 2065926
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
[TBL] [Abstract][Full Text] [Related]
19. A physiological role for cholecystokinin as a regulator of gastrin secretion.
Beglinger C; Hildebrand P; Meier R; Bauerfeind P; Hasslocher H; Urscheler N; Delco F; Eberle A; Gyr K
Gastroenterology; 1992 Aug; 103(2):490-5. PubMed ID: 1634067
[TBL] [Abstract][Full Text] [Related]
20. Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.
Hildebrand P; Ensinck JW; Ketterer S; Delco F; Mossi S; Bangerter U; Beglinger C
J Clin Endocrinol Metab; 1991 May; 72(5):1123-9. PubMed ID: 2022712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
